GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,296 | +33.3% | 3,800 | 0.0% | 0.00% | – |
| Q2 2023 | $5,472 | -31.4% | 3,800 | 0.0% | 0.00% | – |
| Q1 2023 | $7,980 | +85.8% | 3,800 | 0.0% | 0.00% | – |
| Q4 2022 | $4,294 | -28.4% | 3,800 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 3,800 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -16.7% | 3,800 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -25.0% | 3,800 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -46.7% | 3,800 | 0.0% | 0.00% | – |
| Q3 2021 | $15,000 | +25.0% | 3,800 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | +50.0% | 3,800 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -20.0% | 3,800 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | 0.0% | 3,800 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -16.7% | 3,800 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $12,000 | +71.4% | 3,800 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -36.4% | 3,800 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | – | 3,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |